Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Juvify is a private health and longevity company founded by Buck Institute researcher Pankaj Kapahi to commercialize science-backed products focused on healthy aging, fasting support, and metabolic health. Its lead and currently visible commercial product is GLYLO, a patent-pending dietary supplement positioned for healthy aging and weight management. The company’s scientific rationale centers on lowering glycation and advanced glycation end products, which it links to appetite, metabolic dysfunction, and age-related disease biology. Juvify appears to operate primarily as a consumer health and nutraceutical business rather than a traditional clinical-stage drug developer, although third-party reporting has indicated interest in future human clinical studies for GLYLO. The company is closely associated with research originating from the Buck Institute for Research on Aging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Juvify.